Odyssey Therapeutics (ODTX) Asset Utilization Ratio (2026)
Odyssey Therapeutics' (ODTX) Asset Utilization Ratio came in at 0.00 for Q2 2026, down 93.5% from the prior quarter.
Analysis
Odyssey Therapeutics (ODTX) Asset Utilization Ratio (2026) Analysis & Trends
For FY2025, Odyssey Therapeutics' Asset Utilization Ratio stood at 0.01, down 31.1% from FY2024.
- In prior years, Odyssey Therapeutics' Asset Utilization Ratio was 0.02 in FY2024 (+437.9%) and 0.00 in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 0.31 |
| 10 | Odyssey Therapeutics | 929.15 Mn | -64.53 Mn | - | - |
API Access
Odyssey Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ODTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ODTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ODTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();